Cita APA (7a ed.)
Weycker, D., Li, X., Figueredo, J., Barron, R., Tzivelekis, S., & Hagiwara, M. (2016). Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: Does timing of administration matter? Supportive Care in Cancer, 24(5), 2309-2317.
Cita Chicago Style (17a ed.)
Weycker, Derek, Xiaoyan Li, Jacqueline Figueredo, Rich Barron, Spiros Tzivelekis, y May Hagiwara. "Risk of Chemotherapy-induced Febrile Neutropenia in Cancer Patients Receiving Pegfilgrastim Prophylaxis: Does Timing of Administration Matter?" Supportive Care in Cancer 24, no. 5 (2016): 2309-2317.
Cita MLA (9a ed.)
Weycker, Derek, et al. "Risk of Chemotherapy-induced Febrile Neutropenia in Cancer Patients Receiving Pegfilgrastim Prophylaxis: Does Timing of Administration Matter?" Supportive Care in Cancer, vol. 24, no. 5, 2016, pp. 2309-2317.
Precaución: Estas citas no son 100% exactas.